Abstract
Major histocompatibility complex (MHC) class II deficiency is a rare form of primary combined immunodeficiency that can only be corrected by stem cell transplantation. We report a 4½-year-old girl with MHC class II deficiency who underwent a related CBT due to graft failure following T cell-depleted non-identical BMT. The patient is alive and well 2 years after the second transplant. A sustained hematopoietic engraftment and a progressive immune recovery have been detected. We conclude that cord blood may be an effective source of hematopoietic stem cells for patients with immuno- deficiency disorders including diseases with a high rate of graft failure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonduel, M., del Pozo, A., Zelazko, M. et al. Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant 24, 437–440 (1999). https://doi.org/10.1038/sj.bmt.1701915
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1701915
- Springer Nature Limited
Keywords
This article is cited by
-
Alternative donor SCT for the treatment of MHC Class II deficiency
Bone Marrow Transplantation (2013)
-
Unrelated cord blood transplantation and reduced-intensity conditioning regimen for graft failure in a child with Major Histocompatibility Complex class II deficiency
Bone Marrow Transplantation (2009)
-
Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency
Bone Marrow Transplantation (2005)
-
Unrelated cord blood transplant as salvage following non-engraftment of unrelated marrow transplant?
Bone Marrow Transplantation (2004)